ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 97 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 41,873 | $46 | 0.00% |
| Citadel Advisors | 13,200 | $14,520 | 0.00% |
| Citadel Advisors | 3,300 | $3,630 | 0.00% |
| Citadel Advisors | 875,216 | $962,738 | 0.00% |
| Covestor Ltd | 62 | $0 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 19,200 | $21,120 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 206,600 | $227,260 | 0.00% |
| Verition Fund Management LLC | 82,883 | $91,171 | 0.00% |
| JPMORGAN CHASE & CO | 8,904 | $9,794 | 0.00% |
| Neuberger Berman Group LLC | 12,656 | $13,922 | 0.00% |
| HRT FINANCIAL LP | 81,005 | $89 | 0.00% |
| Daiwa Securities Group Inc. | 248 | $0 | 0.00% |
| Farther Finance Advisors, LLC | 99 | $114 | 0.00% |
| Halpern Financial, Inc. | 1,500 | $1,650 | 0.00% |
| SIMPLEX TRADING, LLC | 10,166 | $11 | 0.00% |
| GOLDMAN SACHS GROUP INC | 916,620 | $1,008,282 | 0.00% |
| Tower Research Capital LLC (TRC) | 20,066 | $22,072 | 0.00% |
| MORGAN STANLEY | 186,343 | $204,977 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 33,183 | $36,501 | 0.00% |
| GROUP ONE TRADING, L.P. | 5,549 | $6,104 | 0.00% |
External links
This page lists ACLARIS THERAPEUTICS INC's shareholders in Q2 2024. To view ACLARIS THERAPEUTICS INC's shareholder history, click here.